FNCH
FNCH 25 articles

Finch Therapeutics Group (NASDAQ:FNCH) Stock Price Down 2.7% – Here’s What Happened

defenseworld.net·Mar 19

Critical Contrast: Eloxx Pharmaceuticals (NASDAQ:ELOX) & Finch Therapeutics Group (NASDAQ:FNCH)

defenseworld.net·Jan 22

Contrasting Finch Therapeutics Group (NASDAQ:FNCH) and Eloxx Pharmaceuticals (NASDAQ:ELOX)

defenseworld.net·Jan 22

Financial Survey: ZIVO Bioscience (NASDAQ:ZIVO) versus Finch Therapeutics Group (NASDAQ:FNCH)

defenseworld.net·Jan 6

Arquitos Capital's Largest Holdings  For Q1 2025

seekingalpha.com·Apr 30

Finch Announces Delisting from Nasdaq and SEC Deregistration

globenewswire.com·Oct 21

4 Penny Stocks To Buy According To Analysts, Targets Up To 1,650%

pennystocks.com·Apr 19

Finch Therapeutics Group, Inc. (FNCH) Reports Q3 Loss, Misses Revenue Estimates

zacks.com·Nov 10

Finch Therapeutics Group, Inc. (FNCH) Upgraded to Buy: Here's Why

zacks.com·Sep 5

Finch Therapeutics to Host Corporate Update Conference Call and Webcast on May 16, 2022

globenewswire.com·May 9

Why Finch Therapeutics Stock Is Skyrocketing Today

fool.com·Apr 29

Why Is Finch Therapeutics (FNCH) Stock Up 30% Today?

investorplace.com·Apr 29

Best Penny Stocks to Buy Today? 3 to Watch on April 29th

pennystocks.com·Apr 29

Finch Therapeutics' C. Difficile Infection Candidate Meets Primary Goal In Mid-Stage Study

benzinga.com·Nov 10

Finch Therapeutics to Present at the Jefferies Virtual Next Generation IBD Therapeutics Summit

globenewswire.com·Oct 12

Finch Therapeutics Appoints Samuel Allen Hamood to its Board of Directors

globenewswire.com·Oct 5

Finch Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

globenewswire.com·Sep 7

Finch Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update

globenewswire.com·Aug 10

Finch Therapeutics Announces Takeda to Accelerate Leadership Role in FIN-524 Ulcerative Colitis Development Program

globenewswire.com·Aug 10

Finch Therapeutics Added to Russell 2000 and Russell 3000 Indexes

globenewswire.com·Jun 28

Finch Therapeutics: Gut Instinct Says Buy

seekingalpha.com·Jun 14

Finch Therapeutics to Present at Upcoming Virtual Investor Conferences

globenewswire.com·May 28

Finch Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Updates

globenewswire.com·May 13

US IPO Weekly Recap: The IPO Market Heats Up In An 11 IPO Week

seekingalpha.com·Mar 21

Finch Therapeutics Announces Pricing of Upsized Initial Public Offering

globenewswire.com·Mar 18
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.